AERIS THERAPEUTICS, INC.

Basic Information

AERIS THERAPEUTICS, INC.
10K GILL ST
WOBURN, MA, 01801 0172

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Pneumoreductive Surfactant Therapy for Emphysema

    Amount: $855,484.00

    DESCRIPTION (provided by applicant): Aeris therapeutics is developing a novel medical treatment for patients with advanced emphysema known as Pneumoreductive Surfactant (PRS). PRSs are inhaled drugs ...

    SBIR Phase II 2006 Department of Health and Human Services
  2. Enzymatic Pleurodesis for Malignant Pleural Effusions

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): This Phase I SBIR application is presented by Aeris Therapeutics, Inc. of Woburn, MA. It will examine the feasibility of using a novel enzyme based-system to p ...

    SBIR Phase I 2005 Department of Health and Human Services
  3. Pneumedoreductive Surfacant- New Therapy for Emphysema

    Amount: $95,000.00

    DESCRIPTION (provided by applicant): This Phase I SBIR application is presented by Bistech, Inc. of Woburn, MA. It will test the feasibility of using a new inhaled pharmaceutical agent, pneumoreductiv ...

    SBIR Phase I 2004 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government